{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:04:49Z","timestamp":1760267089881},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T00:00:00Z","timestamp":1299196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10549-011-1423-4","type":"journal-article","created":{"date-parts":[[2011,3,3]],"date-time":"2011-03-03T08:10:30Z","timestamp":1299139830000},"page":"157-164","source":"Crossref","is-referenced-by-count":9,"title":["Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy"],"prefix":"10.1007","volume":"129","author":[{"given":"Ingrid E.","family":"Fakkert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kees","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Oosterwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian J. E.","family":"Mourits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geertruida H.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,4]]},"reference":[{"key":"1423_CR1","unstructured":"Nederlandse kankerregistratie (2008) Borstkankerincidentie in vrouwen per 100 000. IKCnet. http:\/\/www.ikcnet.nl\/ . Accessed 17 February 2011"},{"key":"1423_CR2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","volume":"73","author":"EB Claus","year":"1994","unstructured":"Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73:643\u2013651","journal-title":"Cancer"},{"key":"1423_CR3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"1423_CR4","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329\u20131333","journal-title":"J Clin Oncol"},{"key":"1423_CR5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10549-010-0805-3","volume":"124","author":"DM Kolk Van der","year":"2010","unstructured":"Van der Kolk DM, De Bock GH, Leegte BK, Schaapveld M, Mourits MJ, De Vries J, Van der Hout AH, Oosterwijk JC (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124:643\u2013651","journal-title":"Breast Cancer Res Treat"},{"key":"1423_CR6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van \u2018t Veer L, Garber JE, Evans GR et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22:1055\u20131062","journal-title":"J Clin Oncol"},{"key":"1423_CR7","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1245\/s10434-007-9449-x","volume":"14","author":"BA Heemskerk-Gerritsen","year":"2007","unstructured":"Heemskerk-Gerritsen BA, Brekelmans CT, Menke-Pluymers MB, van Geel AN, Tilanus-Linthorst MM, Bartels CC, Tan M et al (2007) Prophylactic mastectomy in BRCA1\/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. Ann Surg Oncol 14:3335\u20133344","journal-title":"Ann Surg Oncol"},{"key":"1423_CR8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427\u2013437","journal-title":"N Engl J Med"},{"key":"1423_CR9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317\u20131325","journal-title":"JAMA"},{"key":"1423_CR10","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","volume":"365","author":"MO Leach","year":"2005","unstructured":"Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, Gilbert FJ et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769\u20131778","journal-title":"Lancet"},{"key":"1423_CR11","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1200\/JCO.2004.00.4960","volume":"23","author":"CK Kuhl","year":"2005","unstructured":"Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469\u20138476","journal-title":"J Clin Oncol"},{"key":"1423_CR12","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","volume":"28","author":"AJ Rijnsburger","year":"2010","unstructured":"Rijnsburger AJ, Obdeyn I, Kaas R, Tilanus-Linthors MMA, Boetes C, Loo CE et al (2010) BRCA1-Associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC study. J Clin Oncol 28:5265\u20135273","journal-title":"J Clin Oncol"},{"key":"1423_CR13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ijc.24038","volume":"124","author":"NM Velde Van de","year":"2009","unstructured":"Van de Velde NM, Mourits MJ, de VJ, Arts HJ, Leegte BK, Dijkhuis G, Oosterwijk JC et al (2009) Time to stop ovarian cancer screening in BRCA1\/2 mutation carriers? Int J Cancer 124:919\u2013923","journal-title":"Int J Cancer"},{"key":"1423_CR14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","volume":"96","author":"BB Hermsen","year":"2007","unstructured":"Hermsen BB, Olivier RI, Verheijen RH, van Beurden M, de Hullu JA, Massuger LF, Burger CW, Brekelmans CT, Mourits MJ, de Bock GH, Gaarenstroom KN, van Boven HH, Mooij TM, Rookus MA (2007) No efficacy of annual gynaecological screening in BRCA1\/2 mutation carriers; an observational follow-up study. Br J Cancer 96:1335\u20131342","journal-title":"Br J Cancer"},{"key":"1423_CR15","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2003.09.052","volume":"21","author":"H Meijers-Heijboer","year":"2003","unstructured":"Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E et al (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21:1675\u20131681","journal-title":"J Clin Oncol"},{"key":"1423_CR16","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ijc.23340","volume":"122","author":"KA Metcalfe","year":"2008","unstructured":"Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P et al (2008) International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122:2017\u20132022","journal-title":"Int J Cancer"},{"key":"1423_CR17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80\u201387","journal-title":"J Natl Cancer Inst"},{"key":"1423_CR18","unstructured":"Kwaliteitsinstituut voor de Gezondheidszorg CBO (2008) Richtlijn mammacarcinoom 2008. CBO. http:\/\/www.cbo.nl\/Downloads\/328\/rl_mamma_08.pdf . Accessed 17 February 2011"},{"key":"1423_CR19","unstructured":"National Institute of Clinical Excellence (NICE) (2006) National Institute of Clinical Excellence (NICE) guideline CG41 Familial Breast Cancer 2004 updated in 2006. NICE. http:\/\/www.nice.org.uk\/CG41 . Accessed 17 February 2011"},{"key":"1423_CR20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.maturitas.2010.03.018","volume":"66","author":"MJ Kenkhuis","year":"2010","unstructured":"Kenkhuis MJ, de Bock GH, Elferink PO, Arts HJ, Oosterwijk JC, Jansen L, Mourits MJ (2010) Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers. Maturitas 66:310\u2013314","journal-title":"Maturitas"},{"key":"1423_CR21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejrad.2006.08.036","volume":"61","author":"AA Tardivon","year":"2007","unstructured":"Tardivon AA, Athanasiou A, Thibault F, El Khoury C (2007) Breast imaging and reporting data system (BIRADS): magnetic resonance imaging. Eur J Radiol 61:212\u2013215","journal-title":"Eur J Radiol"},{"key":"1423_CR22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0033-8389(01)00017-3","volume":"40","author":"L Liberman","year":"2002","unstructured":"Liberman L, Menell JH (2002) Breast imaging reporting and data system (BI-RADS). Radiol Clin N Am 40:409\u2013430","journal-title":"Radiol Clin N Am"},{"key":"1423_CR23","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00330-004-2593-9","volume":"15","author":"S Obenauer","year":"2005","unstructured":"Obenauer S, Hermann KP, Grabbe E (2005) Applications and literature review of the BI-RADS classification. Eur Radiol 15:1027\u20131036","journal-title":"Eur Radiol"},{"key":"1423_CR24","unstructured":"Lowry R (2008) Clinical calculator 1: from an observed sample\u2014estimates of population prevalence, sensitivity, specificity, predictive values, and likelihood ratios. VassarStats. http:\/\/faculty.vassar.edu\/lowry\/clin1.html . Accessed 17 February 2011"},{"key":"1423_CR25","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnci\/djp241","volume":"101","author":"AM Chiarelli","year":"2009","unstructured":"Chiarelli AM, Majpruz V, Brown P, Th\u00e9riault M, Shumak R, Mai V (2009) The contribution of clinical breast examination to the accuracy of breast screening. J Natl Cancer Inst 101:1236\u20131243","journal-title":"J Natl Cancer Inst"},{"key":"1423_CR26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10549-009-0607-7","volume":"119","author":"IM Obdeijn","year":"2010","unstructured":"Obdeijn IM, Loo CE, Rijnsburger AJ, Wasser MNJM, Bergers E, Kok T et al (2010) Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition. Breast Cancer Res Treat 119:399\u2013407","journal-title":"Breast Cancer Res Treat"},{"key":"1423_CR27","doi-asserted-by":"crossref","unstructured":"Lu W, de Bock GH, Schaapveld M, Baas PC, Wiggers T, Jansen L (2010) The value of routine physical examination in the follow up of women with a history of early breast cancer. Eur J Cancer (in press)","DOI":"10.1016\/S1359-6349(10)70644-3"},{"key":"1423_CR28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0015-0282(01)01935-5","volume":"76","author":"F Senda\u011f","year":"2001","unstructured":"Senda\u011f F, Co\u015fan Terek M, Oz\u015fener S, Oztekin K, Bilgin O, Bilgen I et al (2001) Mammographic density changes during different postmenopausal hormone replacement therapies. Fertil Steril 76:445\u2013450","journal-title":"Fertil Steril"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1423-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1423-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1423-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T19:49:07Z","timestamp":1560023347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1423-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1423"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1423-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,4]]}}}